Argonaut Manufacturing Services, a contract manufacturing organization (CMO), and n-Lorem, a nonprofit foundation, have formed a new partnership that supports and reduces the cost of manufacturing of n-Lorem’s experimental antisense oligonucleotide (ASO) medicines developed for nano-rare disease patients (1 to 30 patients worldwide) for free, for life. 

“Providing nano-rare patients, who would otherwise be largely ignored by our current drug discovery paradigm, with a personalized approach for free is a remarkable undertaking and one that requires the commitment of many people and organizations,” said Stanley T. Crooke, founder, CEO and chairman of n-Lorem Foundation. “We are pleased to add Argonaut to our growing list of the industry’s best to support the highest-quality drug discovery, development, and manufacturing for our patients. Reducing the cost of manufacturing translates into lower per-patient costs, which is important for our non-profit and important for our patients who depend upon us and our partners. At n-Lorem, we are fortunate that our partners can integrate seamlessly and efficiently with us and together we work toward making a difference for our nano-rare patient today and tomorrow.”

Wayne Woodard, founder and CEO, Argonaut, said, “At Argonaut, we are incredibly proud to be working with this distinguished group of experts at the n-Lorem Foundation. We are focused on delivering the best contract manufacturing support to the innovators and creators, in the biopharma industry. Partnering with the n-Lorem Foundation provides us with the unique opportunity to apply our leading aseptic drug product manufacturing technology in support of nano-rare patients. I have been impressed with Stan’s vision and leadership with n-Lorem’s charitable approach, and the overall progress of the foundation in such a short time. We are committed strategic partners as we understand that there are > 7,000 known rare to nano-rare diseases. Stan and I share a vision that these patient groups will have access to the life improving or lifesaving drugs that need to be developed. As such, we are honored to work with n-Lorem.”

Learn more about n-Lorem’s mission at www.nlorem.org, and please consider giving to n-Lorem to bring hope, possibility and treatment options to these needy patients and families.

Watch: n-Lorem Foundation Delivers Hope and Treatment for Patient with Nano-Rare Disease
Watch: n-Lorem Foundation: Creating a Better Future for Nano-Rare, One Patient at a Time

Learn more about Argonaut Manufacturing Services, Inc. parenteral injectable aseptic fill finish services. Argonaut will also be establishing a donation campaign on its website and be available at select conferences with n-Lorem leaders and patients throughout the year to advance the education and ability for n-Lorem and the community to save patients lives, an “n of 1” at a time.